Phased formulations of ethinylestradiol vs Medroxyprogesterone acetate
Medroxyprogesterone acetate was dispensed 69.0× as often as Phased formulations of ethinylestradiol in March 2026 — 57,953 items versus 840 in England.
840items
Phased formulations of ethinylestradiol · March 2026
NHSBSA Prescription Cost Analysis
57,953items
Medroxyprogesterone acetate · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Phased formulations of ethinylestradiol versus Medroxyprogesterone acetate: national items dispensed by month
▬ Phased formulations of ethinylestradiol · ╌ Medroxyprogesterone acetate
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Phased formulations of ethinylestradiol | Medroxyprogesterone acetate |
|---|---|---|
| Items, March 2026 | 840 | 57,953 |
| Items, last 12 months | 11,746 | 733,535 |
| Net ingredient cost, March 2026 | £4,742 | £376,524 |
See the full profile for Phased formulations of ethinylestradiol or Medroxyprogesterone acetate.